Spencer Fane was pleased to return as a Silver Partner for Informa’s Annual Pharma IPR India Conference on February 16-18 in Mumbai. Attorney Jeremy Lowe once again presented at the international intellectual property event.
Pharma IPR allows industry stakeholders and thought leaders to explore effective strategies for IP management, navigating new legal developments, and more. Jeremy led the session Winning After Losing: Redesign Under HWA & BPCIA, which discussed IP and pharmaceutical litigation under the Hatch-Waxman and Biologics Price Competition and Innovation Acts.
At Spencer Fane, Jeremy leads the firm’s Hatch-Waxman and Biologics Litigation group, representing clients as first chair in complex patent trials and appeals. With over 25 years of experience, he is a Fellow of the Litigation Counsel of America, Order of Certus, Barrister – an honor reserved for the top 0.5% of lawyers, judges, and legal scholars.